Clinical Trial Update: Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

View source ↗

Summary

A completed clinical trial update evaluated the risk of developing antibodies to heparin-PF4 after heart surgery. This immune response is associated with hepari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia
• Thrombosis

Snippet

Sponsor: Duke University | Conditions: Thrombosis | Status: COMPLETED